Related references
Note: Only part of the references are listed.Clinical usefulness of bone turnover marker concentrations in osteoporosis
H. A. Morris et al.
CLINICA CHIMICA ACTA (2017)
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis
Maurizio Rossini et al.
CALCIFIED TISSUE INTERNATIONAL (2016)
Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study
K. E. Naylor et al.
OSTEOPOROSIS INTERNATIONAL (2016)
The effect of sphingosine-1-phosphate on bone metabolism in humans depends on its plasma/bone marrow gradient
B. -J. Kim et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2016)
Biochemical bone turnover markers in diabetes mellitus - A systematic review
Jakob Starup-Linde et al.
BONE (2016)
Bone turnover biomarkers and risk of osteoporotic hip fracture in an Asian population
Zhaoli Dai et al.
BONE (2016)
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis
Giovanni Adami et al.
CALCIFIED TISSUE INTERNATIONAL (2016)
Sclerostin Inhibition in the Management of Osteoporosis
Natasha M. Appelman-Dijkstra et al.
CALCIFIED TISSUE INTERNATIONAL (2016)
Atorvastatin Reduces Circulating Osteoprogenitor Cells and T-Cell RANKL Expression in Osteoporotic Women: Implications for the Bone-Vascular Axis
Marcello Rattazzi et al.
CARDIOVASCULAR THERAPEUTICS (2016)
Decreased Cathepsin K Plasma Level may Reflect an Association of Osteopoenia/Osteoporosis with Coronary Atherosclerosis and Coronary Artery Calcification in Male Patients with Stable Angina
Olga L. Barbarash et al.
HEART LUNG AND CIRCULATION (2016)
Sclerostin as a new key factor in vascular calcification in chronic kidney disease stages 3 and 4
Wei Lv et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2016)
Serum miRNA Signatures Are Indicative of Skeletal Fractures in Postmenopausal Women With and Without Type 2 Diabetes and Influence Osteogenic and Adipogenic Differentiation of Adipose Tissue-Derived Mesenchymal Stem Cells In Vitro
Ursula Heilmeier et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Circulating microRNA Signatures in Patients With Idiopathic and Postmenopausal Osteoporosis and Fragility Fractures
Roland Kocijan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Circulating microRNAs as novel biomarkers for bone diseases - Complex signatures for multifactorial diseases?
Matthias Hackl et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
Periostin action in bone
Nicolas Bonnet et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
The circulating sphingosine-1-phosphate level predicts incident fracture in postmenopausal women: a 3.5-year follow-up observation study
S. J. Bae et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Differentially circulating miRNAs after recent osteoporotic fractures can influence osteogenic differentiation
Sylvia Weilner et al.
BONE (2015)
Plasma periostin associates significantly with non-vertebral but not vertebral fractures in postmenopausal women: Clinical evidence for the different effects of periostin depending on the skeletal site
Beom-Jun Kim et al.
BONE (2015)
Serum Circulating MicroRNAs as Biomarkers of Osteoporotic Fracture
Layla Panach et al.
CALCIFIED TISSUE INTERNATIONAL (2015)
Role of biochemical markers in the management of osteoporosis
K. Henriksen et al.
CLIMACTERIC (2015)
A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density
Robert R. Recker et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
Reference Intervals for Bone Turnover Markers and Their Association With Incident Hip Fractures in Older Men: The Health In Men Study
S. A. Paul Chubb et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Sclerostin Serum Levels and Vascular Calcification Progression in Prevalent Renal Transplant Recipients
P. Evenepoel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Additive Genetic Effects on Circulating Periostin Contribute to the Heritability of Bone Microstructure
N. Bonnet et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Serum periostin is associated with prevalent knee osteoarthritis and disease incidence/progression in women: the OFELY study
J. C. Rousseau et al.
OSTEOARTHRITIS AND CARTILAGE (2015)
Understanding the local actions of lipids in bone physiology
Alexandrine During et al.
PROGRESS IN LIPID RESEARCH (2015)
Identification of miR-194-5p as a potential biomarker for postmenopausal osteoporosis
Jia Meng et al.
PEERJ (2015)
Plasma miRNA levels correlate with sensitivity to bone mineral density in postmenopausal osteoporosis patients
Hongqiu Li et al.
BIOMARKERS (2014)
Procollagen type 1 amino-terminal propeptide (P1NP) and risk of hip fractures in elderly Norwegian men and women. A NOREPOS study
T. E. Finnes et al.
BONE (2014)
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis
Davide Gatti et al.
BONE (2014)
A Meta-Analysis of Reference Markers of Bone Turnover for Prediction of Fracture
Helena Johansson et al.
CALCIFIED TISSUE INTERNATIONAL (2014)
Periostin and transforming growth factor β-induced protein (TGFβIp) are both expressed by osteoblasts and osteoclasts
Blandine Merle et al.
CELL BIOLOGY INTERNATIONAL (2014)
MiR-503 Regulates Osteoclastogenesis via Targeting RANK
Chao Chen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Single-and Multiple-Dose Randomized Studies of Blosozumab, a Monoclonal Antibody Against Sclerostin, in Healthy Postmenopausal Women
Juliet McColm et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Five Freely Circulating miRNAs and Bone Tissue miRNAs Are Associated With Osteoporotic Fractures
Claudine Seeliger et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Serum Periostin Is Associated With Fracture Risk in Postmenopausal Women: A 7-Year Prospective Analysis of the OFELY Study
J. C. Rousseau et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
The Relationships Between Serum Sclerostin, Bone Mineral Density, and Vascular Calcification in Rheumatoid Arthritis
J. Paccou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Renal Elimination of Sclerostin Increases With Declining Kidney Function
Daniel Cejka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort
Noriko Yoshimura et al.
Modern Rheumatology (2014)
Romosozumab in Postmenopausal Women with Low Bone Mineral Density
Michael R. McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Comparison of two commercially available ELISAs for circulating sclerostin
A. G. Costa et al.
OSTEOPOROSIS INTERNATIONAL (2014)
PINP as a biological response marker during teriparatide treatment for osteoporosis
J. H. Krege et al.
OSTEOPOROSIS INTERNATIONAL (2014)
Biochemical markers of bone turnover - uses and limitations
Thinn Thinn Hlaing et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2014)
Disposition and Metabolism of the Cathepsin K Inhibitor Odanacatib in Humans
Kelem Kassahun et al.
DRUG METABOLISM AND DISPOSITION (2014)
Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and Dkk-1) and their relationship with bone turnover
L. Gifre et al.
BONE (2013)
The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women
Geeta Hampson et al.
BONE (2013)
Reference intervals for serum concentrations of three bone turnover markers for men and women
J. Michelsen et al.
BONE (2013)
Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes
Mohammed-Salleh M. Ardawi et al.
BONE (2013)
The development and characterization of an ELISA specifically detecting the active form of cathepsin K
S. Sun et al.
CLINICAL BIOCHEMISTRY (2013)
Cathepsin K Inhibitors: A Novel Target but Promising Approach in the Treatment of Osteoporosis
Asadul Mazid Helali et al.
CURRENT DRUG TARGETS (2013)
Atherosclerotic Disease in Type 2 Diabetes Is Associated With an Increase in Sclerostin Levels
Sonia Morales-Santana et al.
DIABETES CARE (2013)
Lower fracture risk in older men with higher sclerostin concentration: A prospective analysis from the MINOS study
Pawel Szulc et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Association of Serum Fibroblast Growth Factor 23 (FGF23) and Incident Fractures in Older Men: The Osteoporotic Fractures in Men (MrOS) Study
Nancy E. Lane et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin and Dickkopf-1 Levels of Naive Postmenopausal Women With Low Bone Mass: A Randomized, Head-to-Head Clinical Trial
Athanasios D. Anastasilakis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Association of Circulating Sclerostin With Bone Mineral Mass, Microstructure, and Turnover Biochemical Markers in Healthy Elderly Men and Women
Claire Durosier et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Elevated Sclerostin Levels Are Associated With Vertebral Fractures in Patients With Type 2 Diabetes Mellitus
Masahiro Yamamoto et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Assessment of OPG/RANK/RANKL Gene Expression Levels in Peripheral Blood Mononuclear Cells (PBMC) After Treatment With Strontium Ranelate and Ibandronate in Patients With Postmenopausal Osteoporosis
Michal Stuss et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
miR-214 targets ATF4 to inhibit bone formation
Xiaogang Wang et al.
NATURE MEDICINE (2013)
Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study
P. Garnero et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis
P. Farahmand et al.
OSTEOPOROSIS INTERNATIONAL (2013)
FGF23 production by osteocytes
Lynda F. Bonewald et al.
PEDIATRIC NEPHROLOGY (2013)
Zoledronate Effects on Systemic and Jaw Osteopenias in Ovariectomized Periostin-Deficient Mice
Nicolas Bonnet et al.
PLOS ONE (2013)
Mechanisms With Clinical Implications for Atrial Fibrillation-Associated Remodeling: Cathepsin K Expression, Regulation, and Therapeutic Target and Biomarker
Masaya Fujita et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
MicroRNA Functions in Osteogenesis and Dysfunctions in Osteoporosis
Andre J. van Wijnen et al.
CURRENT OSTEOPOROSIS REPORTS (2013)
Periostin, a Matricellular Protein, Plays a Role in the Induction of Chemokines in Pulmonary Fibrosis
Masaru Uchida et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2012)
High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis
Gisela Ruiz Heiland et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Relationships Between Changes in Bone Mineral Density or Bone Turnover Markers and Vertebral Fracture Incidence in Patients Treated with Bazedoxifene
Olivier Bruyere et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
Circulating Sclerostin and Dickkopf-1 (DKK1) in Predialysis Chronic Kidney Disease (CKD): Relationship with Bone Density and Arterial Stiffness
S. Thambiah et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
The role of bone turnover markers in monitoring treatment in postmenopausal osteoporosis
Pawel Szulc
CLINICAL BIOCHEMISTRY (2012)
Prognostic interest of bone turnover markers in the management of postmenopausal osteoporosis
Florence Chopin et al.
JOINT BONE SPINE (2012)
Bone turnover markers for osteoporotic status assessment? A systematic review of their diagnosis value at baseline in osteoporosis
Emmanuel Biver et al.
JOINT BONE SPINE (2012)
Sclerostin and DKK1 in Postmenopausal Osteoporosis Treated With Denosumab
Davide Gatti et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
High Serum Sclerostin Predicts the Occurrence of Osteoporotic Fractures in Postmenopausal Women: The Center of Excellence for Osteoporosis Research Study
Mohammed-Salleh M. Ardawi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT)
Richard M. Jacques et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Osteocyte RANKL: New insights into the control of bone remodeling
Jinhu Xiong et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Changes of Serum Soluble Receptor Activator for Nuclear Factor-κB Ligand after Glucocorticoid Therapy Reflect Regulation of Its Expression by Osteoblasts
Kaichi Kaneko et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Plasma Sphingosine 1-Phosphate Levels and the Risk of Vertebral Fracture in Postmenopausal Women
Beom-Jun Kim et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Higher Circulating Sphingosine 1-Phosphate Levels Are Associated with Lower Bone Mineral Density and Higher Bone Resorption Marker in Humans
Seung Hun Lee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Serum Sclerostin and Risk of Hip Fracture in Older Caucasian Women
Aarthi Arasu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Skeletal Histomorphometry in Subjects on Teriparatide or Zoledronic Acid Therapy (SHOTZ) Study: A Randomized Controlled Trial
David W. Dempster et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes
Luigi Gennari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus
Antonia Garcia-Martin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Periostin promotes chronic allergic inflammation in response to Th2 cytokines
Miho Masuoka et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
MicroRNA control of bone formation and homeostasis
Jane B. Lian et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
The role of FGF23 in CKD-with or without Klotho
Hirotaka Komaba et al.
NATURE REVIEWS NEPHROLOGY (2012)
Bone turnover markers: use in osteoporosis
Kim Naylor et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Serum Cathepsin K levels are not suitable to differentiate women with chronic bone disorders such as osteopenia and osteoporosis from healthy pre- and postmenopausal women
Daniela Adolf et al.
MATURITAS (2012)
Impact of bone turnover markers and/or educational information on persistence to oral bisphosphonate therapy: a community setting-based trial
S. L. Silverman et al.
OSTEOPOROSIS INTERNATIONAL (2012)
The multiple facets of periostin in bone metabolism
B. Merle et al.
OSTEOPOROSIS INTERNATIONAL (2012)
MiR-133a in Human Circulating Monocytes: A Potential Biomarker Associated with Postmenopausal Osteoporosis
Yang Wang et al.
PLOS ONE (2012)
Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin
Nicolas Bonnet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
XenomiRs and miRNA homeostasis in health and disease Evidence that diet and dietary miRNAs directly and indirectly influence circulating miRNA profiles
Kenneth W. Witwer
RNA BIOLOGY (2012)
PINP as an aid for monitoring patients treated with teriparatide
Mika Tsujimoto et al.
BONE (2011)
Serum Fibroblast Growth Factor-23 (FGF-23) and Fracture Risk in Elderly Men
Majd Ai Mirza et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Determinants of Serum Sclerostin in Healthy Pre- and Postmenopausal Women
Mohammed-Salleh M. Ardawi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Odanacatib in the Treatment of Postmenopausal Women With Low Bone Mineral Density: Three-Year Continued Therapy and Resolution of Effect
John A. Eisman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Bone Turnover Markers and Bone Mineral Density Response With Risedronate Therapy: Relationship With Fracture Risk and Patient Adherence
Richard Eastell et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Relation of Age, Gender, and Bone Mass to Circulating Sclerostin Levels in Women and Men
Ulrike I. Moedder et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
The Waning of Teriparatide Effect on Bone Formation Markers in Postmenopausal Osteoporosis Is Associated with Increasing Serum Levels of DKK1
Davide Gatti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
The Role of Dkk1 in Bone Mass Regulation: Correlating Serum Dkk1 Expression with Bone Mineral Density
Joseph S. Butler et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2011)
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
Kasey C. Vickers et al.
NATURE CELL BIOLOGY (2011)
Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
S. Vasikaran et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Relationship between serum RANKL and RANKL in bone
D. M. Findlay et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Expression and Rhythmic Modulation of Circulating MicroRNAs Targeting the Clock Gene Bmal1 in Mice
Vikram R. Shende et al.
PLOS ONE (2011)
Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
Asiri R. Wijenayaka et al.
PLOS ONE (2011)
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
Jason D. Arroyo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression
Pablo Roman-Garcia et al.
BONE (2010)
The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis
Athanasios D. Anastasilakis et al.
CLINICAL ENDOCRINOLOGY (2010)
The syndromic status of sclerosteosis and van Buchem disease
P. Beighton et al.
CLINICAL GENETICS (2010)
Incorporation of Tenascin-C into the Extracellular Matrix by Periostin Underlies an Extracellular Meshwork Architecture
Isao Kii et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Interaction between Periostin and BMP-1 Promotes Proteolytic Activation of Lysyl Oxidase
Takumi Maruhashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Bone Turnover Markers and Prediction of Fracture: A Prospective Follow-Up Study of 1040 Elderly Women for a Mean of 9 Years
Kaisa K. Ivaska et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Markers of bone resorption predict hip fracture in elderly women: The EPIDOS prospective study
P. Garnero et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
Patrick Garnero et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Serum Sclerostin Levels Negatively Correlate with Parathyroid Hormone Levels and Free Estrogen Index in Postmenopausal Women
Faryal S. Mirza et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo
Masaru Ishii et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Export of microRNAs and microRNA-protective protein by mammalian cells
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
Opposite relationships between circulating Dkk-1 and cartilage breakdown in patients with rheumatoid arthritis and knee osteoarthritis
N. Voorzanger-Rousselot et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Platelet is a major contributor to circulating levels of Dickkopf-1: clinical implications in patients with multiple myeloma
Nathalie Voorzanger-Rousselot et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Impaired Micro-RNA Pathways Diminish Osteoclast Differentiation and Function
Toshifumi Sugatani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The Matricellular Protein Periostin Is Required for Sost Inhibition and the Anabolic Response to Mechanical Loading and Physical Activity
Nicolas Bonnet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Establishing a Reference Interval for Bone Turnover Markers in 637 Healthy, Young, Premenopausal Women From the United Kingdom, France, Belgium, and the United States
Sarah J. Glover et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Biochemical Markers of Bone Turnover, Hip Bone Loss, and Fracture in Older Men: The MrOS Study
Douglas C. Bauer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Sclerostin in Mineralized Matrices and van Buchem Disease
R. L. van Bezooijen et al.
JOURNAL OF DENTAL RESEARCH (2009)
Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis
Masaru Ishii et al.
NATURE (2009)
Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate
Manuel Munoz-Torres et al.
MATURITAS (2009)
Establishing a reference range for bone turnover markers in young, healthy women
S. J. Glover et al.
BONE (2008)
Determinants of bone turnover markers in healthy premenopausal women
Silvano Adami et al.
CALCIFIED TISSUE INTERNATIONAL (2008)
Receptor activator of nuclear factor kappa B ligand and osteoprotegerin regulation of bone remodeling in health and disease
Ann E. Kearns et al.
ENDOCRINE REVIEWS (2008)
Serum levels of MMP-3 and cathepsin K in patients with ankylosing spondylitis: Effect of TNFα antagonist therapy
Daniel Wendling et al.
JOINT BONE SPINE (2008)
Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro
Hua Wang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Sphingosine-1-Phosphate Acts as a Developmental Stage Specific Inhibitor of Platelet-Derived Growth Factor-induced Chemotaxis of Osteoblasts
T. Roelofsen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Biomarkers for osteoporosis management - Utility in diagnosis, fracture risk prediction and therapy monitoring
Patrick Garnero
MOLECULAR DIAGNOSIS & THERAPY (2008)
Cathepsin K predicts femoral neck bone mineral density change in nonosteoporotic peri- and early postmenopausal women
Janez Prezelj et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2008)
Serum MicroRNAs Are Promising Novel Biomarkers
Shlomit Gilad et al.
PLOS ONE (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Evaluation of a fully automated serum assay for total N-terminal propeptide of type I collagen in postmenopausal osteoporosis
Patrick Garnero et al.
CLINICAL CHEMISTRY (2008)
Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women
Nancy E. Lane et al.
ARTHRITIS AND RHEUMATISM (2007)
Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair
Bernhard Kuhn et al.
NATURE MEDICINE (2007)
Effect of fracture on bone turnover markers:: A longitudinal study comparing marker levels before and after injury in 113 elderly women
Kaisa K. Ivaska et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
A cross-sectional study of bone turnover markers in healthy premenopausal women
Anne E. de Papp et al.
BONE (2007)
Dickkopf-1 is a master regulator of joint remodeling
Danielle Diarra et al.
NATURE MEDICINE (2007)
Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis
Tony M. Keaveny et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Hadi Valadi et al.
NATURE CELL BIOLOGY (2007)
Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling
Jiyoon Ryu et al.
EMBO JOURNAL (2006)
Klotho converts canonical FGF receptor into a specific receptor for FGF23
Itaru Urakawa et al.
NATURE (2006)
Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover
PD Delmas et al.
BONE (2006)
Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation
FC Caira et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: The fracture intervention trial
DC Bauer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease - Potential uses and pitfalls
Serge Cremers et al.
DRUGS (2006)
SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor
M Semënov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis
PQ Chen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling
XF Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis
TF Day et al.
DEVELOPMENTAL CELL (2005)
Serum cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction
M Skoumal et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Biochemical markers of bone formation reflect endosteal bone loss in elderly men - MINOS study
P Szulc et al.
BONE (2005)
FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis
T Shimada et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: A randomized controlled
JA Clowes et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate
MJ Seibel et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Transgenic mice expressing fibroblast growth factor 23 under the control of the α1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis
T Larsson et al.
ENDOCRINOLOGY (2004)
Osteoblastic cells express phospholipid receptors and phosphatases and proliferate in response to sphingosine-1-phosphate
A Grey et al.
CALCIFIED TISSUE INTERNATIONAL (2004)
The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma
E Tian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX
SG Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate
R Eastell et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
The phospholipids sphingosine-1-phosphate and lysophosphatidic acid prevent apoptosis in osteoblastic cells via a signaling pathway involving Gi proteins and phosphatidylinositol-3 kinase
A Grey et al.
ENDOCRINOLOGY (2002)
Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (Serum CTx): Effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting
P Qvist et al.
BONE (2002)
Effect of feeding on bone turnover markers and its impact on biological variability of measurements
JA Clowes et al.
BONE (2002)
Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorption
RA Dodds et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
Share Paper
